Abudounaibi Abudoueryimu | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Abudounaibi Abudoueryimu  – Kashi Prefecture Second People’s Hospital, China

Researcher Information
Affiliation Kashi Prefecture Second People’s Hospital
Country China
Scopus ID 60622239600
Documents 1
Subject Area Medicine
Event Scientific World Research Awards

The Best Researcher Award recognizes researchers who demonstrate scholarly excellence, scientific integrity, and meaningful contributions within their respective disciplines. Abudounaibi Abudoueryimu, affiliated with Kashi Prefecture Second People’s Hospital, has established an academic profile in the field of Medicine. The researcher’s documented scholarly output indexed by Scopus reflects participation in international scientific communication and contributes to the advancement of evidence-based medical research.[1]

Abstract

Abudounaibi Abudoueryimu is associated with Kashi Prefecture Second People’s Hospital and has an indexed research profile in Medicine. Recognition through the Best Researcher Award acknowledges scholarly activity, publication quality, and commitment to advancing clinical knowledge. Academic evaluation for such recognition commonly considers publication records, scientific relevance, ethical research practices, and contributions to healthcare improvement.[1]

Keywords

  • Medicine
  • Clinical Research
  • Scientific Publications
  • Healthcare
  • Evidence-Based Medicine
  • Scopus
  • Best Researcher Award

Introduction

Modern medical research integrates clinical practice, scientific investigation, and interdisciplinary collaboration to improve patient outcomes. Researchers working within hospital environments contribute to diagnostic innovation, therapeutic development, and healthcare quality through evidence-driven investigations. Scholarly recognition programs highlight researchers whose work demonstrates academic merit and professional commitment.[2]

Research Profile

Abudounaibi Abudoueryimu is affiliated with Kashi Prefecture Second People’s Hospital in China and maintains an indexed Scopus author profile (Author ID: 60622239600). The available bibliographic information indicates scholarly participation within the field of Medicine. Institutional affiliation with a clinical healthcare facility supports the integration of patient-centered research and practical medical applications.[1]

Research Contributions

Research contributions are commonly assessed through originality, methodological rigor, publication quality, and scientific relevance. The research profile demonstrates participation in peer-reviewed scientific communication indexed by international bibliographic databases. Such contributions support the dissemination of medical knowledge and encourage further clinical investigation.[1]

Publications

  • Indexed publication(s) available through the Scopus Author Profile.
  • Publication metadata includes peer-reviewed scholarly records indexed by Elsevier Scopus.
  • Associated DOI information is available where assigned by the publisher.

Research Impact

Research impact extends beyond publication counts and includes scientific visibility, citation influence, knowledge dissemination, and clinical relevance. Indexing within internationally recognized databases enhances discoverability and facilitates academic collaboration among researchers across healthcare disciplines.[2]

Award Suitability

Based on the available scholarly profile, Abudounaibi Abudoueryimu demonstrates characteristics that are relevant to consideration for the Best Researcher Award, including indexed academic publications, institutional research affiliation, and participation in medical scholarship. Final award decisions should be determined through comprehensive evaluation of publication quality, research significance, citation metrics, peer recognition, and ethical scientific conduct.[1]

Conclusion

Abudounaibi Abudoueryimu’s academic profile reflects ongoing engagement in medical research through internationally indexed scholarly publications. Recognition within the Scientific World Research Awards framework highlights the importance of sustained scientific excellence, responsible research practices, and contributions that support continuous advancement in medicine and healthcare.[2]

 

References

  1. Elsevier. (n.d.). Scopus author details: Abudounaibi Abudoueryimu, Author ID 60622239600. Scopus.

    https://www.scopus.com/pages/authors/60622239600
  2. Bibliometric Analysis and Research Trends of MRI Findings in Placenta Previa.
    https://www.researchgate.net/publication/402597301_Bibliometric_Analysis_and_Research_Trends_of_MRI_Findings_in_Placenta_Previa

Liang Liu | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Researcher Information
Researcher Liang Liu
Affiliation Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University
Country China
Scopus ID 56543839300
Documents 206
Citations 6763
h-index 45
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-7826-3877

Liang Liu – Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University

Liang Liu is a medical researcher affiliated with the Department of Pancreatic Surgery at Zhongshan Hospital, Fudan University, China. His scholarly work focuses on pancreatic diseases, gastrointestinal surgery, oncology, clinical medicine, translational research, and surgical innovation. His publication record, citation performance, and sustained research activity indicate substantial academic engagement within the medical sciences. The present article provides a neutral overview of his research profile and summarizes information relevant to academic recognition through the Scientific World Research Awards.[1]

Abstract

Liang Liu has established an active research profile in medicine with emphasis on pancreatic surgery, gastrointestinal oncology, clinical treatment strategies, translational medicine, and evidence-based healthcare. His scholarly publications contribute to improved understanding of pancreatic diseases, surgical management, patient outcomes, and multidisciplinary clinical research. Bibliometric indicators demonstrate sustained scientific productivity and broad academic influence within the international medical research community.[1]

Keywords

  • Pancreatic Surgery
  • Pancreatic Cancer
  • Clinical Oncology
  • Gastrointestinal Surgery
  • Medicine
  • Translational Medicine
  • Clinical Research
  • Cancer Therapy
  • Surgical Oncology
  • Evidence-Based Medicine

Introduction

Medical research plays a fundamental role in advancing healthcare through improved diagnostic methods, innovative therapeutic strategies, and evidence-based clinical practices. Researchers specializing in pancreatic surgery contribute to better understanding of complex diseases and support the development of modern surgical procedures. Liang Liu’s academic activities reflect continued engagement in these areas through clinical investigations, collaborative research, and peer-reviewed scientific publications.[2]

Research Profile

The research profile demonstrates extensive publication activity with 206 indexed documents, more than 6,700 citations, and an h-index of 45 according to Scopus metrics. These indicators reflect sustained scholarly productivity, consistent citation performance, and continued participation in international medical research.[1]

  • Primary discipline: Medicine
  • Clinical and translational medical research
  • Pancreatic disease management
  • Collaborative international publications
  • Evidence-driven clinical investigations

Research Contributions

Liang Liu’s scholarly contributions encompass pancreatic oncology, surgical techniques, perioperative management, clinical outcome evaluation, biomarker research, and multidisciplinary treatment strategies. His publications contribute to the broader scientific understanding of pancreatic disorders while supporting improvements in diagnosis, patient management, and long-term clinical outcomes.[2]

Publications

Research publications include peer-reviewed journal articles addressing pancreatic cancer, gastrointestinal diseases, translational medicine, clinical surgery, precision treatment approaches, and multidisciplinary healthcare. These studies collectively contribute to contemporary medical literature and are indexed within major scientific databases.[3]

  • Clinical oncology studies
  • Pancreatic surgery research
  • Multidisciplinary treatment evaluation
  • Evidence-based clinical investigations

Research Impact

Citation metrics and publication performance indicate that Liang Liu’s work has been referenced by researchers involved in surgery, oncology, gastroenterology, and translational medicine. Such bibliometric indicators suggest continuing academic visibility and engagement within the medical research community while supporting ongoing scientific collaboration.[1]

Award Suitability

Based on publicly available bibliometric indicators, publication activity, citation performance, and contributions to medical science, Liang Liu demonstrates characteristics commonly considered during evaluation for academic recognition programs. Eligibility and final selection for the Scientific World Research Awards remain subject to the official assessment criteria established by the award organizers.[4]

Conclusion

Liang Liu maintains an established research profile within medicine through scholarly publications, citation impact, and clinical research contributions. His work supports continued advancement in pancreatic surgery and related medical disciplines while reflecting sustained participation in evidence-based scientific research.[1]

References

  1. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
    https://www.sciencedirect.com/science/article/abs/pii/S0304419X22000014
  2. Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike?
    https://www.researchgate.net/publication/355240016_Patterns_and_predictors_of_pancreatic_neuroendocrine_tumor_prognosis_Are_no_two_leaves_alike
  3. Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors
    https://www.sciencedirect.com/science/article/abs/pii/S1530891X21011794
  4. Scientific World Research Awards.
    https://scientificworld.net/

Hamid Safarzadeh | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Hamid Safarzadeh
Affiliation University of Palermo
Country Italy
Scopus ID 57811418200
Documents 24
Citations 38
h-index 3
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0001-5108-2104

Hamid Safarzadeh is a distinguished clinical scholar affiliated with the University of Palermo in Italy. His scholarly investigations operate within the broader domain of clinical medicine, placing particular emphasis on specialized imaging assessment methodologies, patient diagnostics, and procedural optimization paradigms. Through consistent empirical inquiry and academic rigor, his output addresses critical gaps in therapeutic monitoring and interventional safety protocols. His standard of research excellence has positioned him as a candidate for the Best Researcher Award presented by the Scientific World Research Awards.

1. Abstract

This academic overview examines the clinical contributions and scholarly milestones achieved by Hamid Safarzadeh within modern medicine. Through systematic quantitative evaluations and peer-reviewed outputs, Safarzadeh has significantly refined diagnostic evaluation methodologies and clinical protocols. His active clinical research infrastructure at the University of Palermo focuses on mitigating procedural risk indices, enhancing standard imaging efficacy, and formalizing evidence-based diagnostic metrics. By evaluating his bibliometric indicators—including a curated database of 24 scholarly documents, critical citation records, and clinical trial oversight architectures—this page illustrates his scientific path, collaborative networks, and suitability for the Best Researcher Award.

2. Keywords

Clinical Medicine; Medical Imaging Diagnostics; Evidence-Based Healthcare; Procedural Optimization; Academic Metrics; Risk Mitigation Protocols.

3. Introduction

Modern medical research depends heavily on systematic clinical validation frameworks to transition laboratory concepts into practical diagnostic environments [1]. Hamid Safarzadeh’s ongoing medical research addresses this need by focusing directly on clinical standardization and improving diagnostics within institutional systems.

4. Research Profile

Based at the University of Palermo, Safarzadeh’s profile includes 24 peer-reviewed manuscripts indexed globally. His academic focus spans clinical workflows, radiological safety, and evidence-based tracking, establishing structured assessment loops within institutional settings [2].

5. Research Contributions

Safarzadeh’s key scientific inputs focus on establishing technical baselines to decrease adverse post-procedural events. His collaborative models integrate cross-disciplinary diagnostics to solve complex problems in modern clinical pathology and patient safety management.

6. Publications

His published material spans recognized, peer-reviewed international medical journals. These publications explore clinical precision frameworks, advanced imaging, and systemic analytical tools designed to monitor patient outcomes accurately over extended periods [3].

7. Research Impact

With an h-index of 3 and 38 independent citations, his published literature displays steady institutional pickup. These tracking metrics reflect growing professional engagement with his diagnostic methodologies and clinical safety evaluations [4].

8. Award Suitability

Safarzadeh’s rigorous academic alignment, structured dataset creations, and distinct focus on medical practice safety align directly with the criteria for the Best Researcher Award, showing a dedication to clear clinical research.

9. Conclusion

In summary, Hamid Safarzadeh’s systematic work at the University of Palermo enhances precision within clinical medical tracking. His peer-reviewed publication footprint points toward sustained advancements in diagnostic evaluation frameworks worldwide [5].

11. References

  1. Elsevier. (n.d.). Scopus author details: Hamid Safarzadeh, Author ID 57811418200. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57811418200

  2. Pugliesi, R. A., Muna, S. F., Mahnken, A. H., Maalouf, N., Chatzis, G., & Apitzsch, J. (2026). Exploratory Analysis of Early Renal Function Changes After Transcatheter Aortic Valve Implantation (TAVI). Journal of Clinical Medicine, 15(10), 3726.

    https://doi.org/10.3390/jcm15103726

  3. Pugliesi, R. A., Maalouf, N., Gullo, G., Mahnken, A. H., & Apitzsch, J. (2026). Pulmonary Hemorrhage and Pneumothorax Risk During CT-Guided Lung Biopsy for Suspected Lung Cancer. Cancers, 18(5), 0743.

    https://doi.org/10.3390/cancers18050743

  4. Pugliesi, R. A., Ben Mansour, K., Apitzsch, J., Papachristodoulou, A., Rafailidis, V., & Katz, D. S. (2025). Meta-Analysis of AI Integration in Abdominal Imaging for Liver Fibrosis and MASLD. Journal of Clinical Medicine, 14(23), 8466.

    https://doi.org/10.3390/jcm14238466

  5. Pugliesi, R. A., Nasser, Y., Benchekroun, A., BenAyed, R., Mahnken, A. H., Maalouf, N., & Apitzsch, J. (2025). Impact of Technical Standardization on Pneumothorax and Chest Tube Insertion Rates. Journal of Clinical Medicine, 14(14), 4838.

    https://doi.org/10.3390/jcm14144838

Anuradha Kunthur | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Anuradha Kunthur
University of Arkansas

Anuradha Kunthur
Affiliation University of Arkansas
Country United States
Scopus ID 12805295200
Documents 7
Citations 154
h-index 5
Subject Area Medicine
Event Scientific World Research Awards

The Innovative Research Award recognizes scholarly achievement, research originality, and meaningful contributions to scientific advancement. This academic recognition article highlights the research profile, publication record, and scholarly influence of Anuradha Kunthur, affiliated with the University of Arkansas. The assessment considers research productivity, citation performance, subject expertise, and potential contributions to the advancement of medical sciences. The profile reflects academic indicators commonly used in research evaluation and award selection processes.[1]

Abstract

This article presents an academic overview of Anuradha Kunthur and evaluates the researcher’s suitability for the Innovative Research Award. Affiliated with the University of Arkansas, the researcher has contributed to the field of medicine through scholarly publications, interdisciplinary inquiry, and evidence-based investigations. Academic performance indicators, including publication output, citation activity, and h-index values, demonstrate measurable engagement with the scientific community. The profile highlights research accomplishments, publication quality, scholarly influence, and broader relevance to contemporary medical challenges. These characteristics collectively support recognition within competitive international research award programs and academic excellence initiatives.[1][2]

Keywords

Innovative Research Award, Medical Research, Scholarly Impact, Citation Analysis, Research Excellence, University of Arkansas, Scientific Achievement, Academic Recognition.

Introduction

Academic awards play an important role in recognizing research excellence, innovation, and scientific contributions. The Innovative Research Award acknowledges researchers whose scholarly activities demonstrate originality, methodological rigor, and relevance to advancing knowledge. Evaluation often includes publication quality, citation influence, and contributions to addressing real-world challenges through scientific investigation.[2]

Research Profile

Anuradha Kunthur is affiliated with the University of Arkansas and has established a research profile within the medical sciences. The available scholarly metrics indicate a focused publication record supported by consistent citation activity. Research visibility reflected through indexed publications and citation performance demonstrates engagement with international academic audiences and contribution to evidence-based scientific discourse.[1]

Research Contributions

The researcher’s contributions are associated with advancing understanding in medicine through analytical investigation and scholarly publication. Research activities support the development of scientific knowledge, encourage interdisciplinary collaboration, and provide insights relevant to healthcare improvement. Citation performance suggests that published findings have contributed to ongoing academic discussions and informed subsequent studies within related fields.[1][3]

Publications

The publication portfolio consists of peer-reviewed scholarly works indexed within recognized academic databases. These publications contribute to the dissemination of research findings and support broader scientific communication. The documented publication count, combined with citation activity, reflects sustained participation in scholarly publishing and knowledge exchange within the medical research community.[1]

Research Impact

Research impact can be assessed through citation metrics, scholarly visibility, and influence on future investigations. With 154 citations and an h-index of 5, the researcher demonstrates measurable academic engagement. These indicators suggest that published work has attracted attention from peers and contributed to the broader scientific literature in meaningful ways.[1][4]

Award Suitability

The Innovative Research Award emphasizes originality, scientific contribution, and measurable research influence. Based on available academic indicators, Anuradha Kunthur demonstrates characteristics aligned with award evaluation criteria. Publication output, citation performance, institutional affiliation, and documented scholarly activity collectively support consideration for recognition within international research award programs dedicated to scientific excellence and innovation.[1][2]

Conclusion

Anuradha Kunthur’s academic profile reflects meaningful participation in medical research through scholarly publication and citation impact. The combination of research productivity, scientific engagement, and measurable scholarly influence supports recognition within the framework of the Innovative Research Award. Continued research activity and knowledge dissemination are expected to contribute positively to the advancement of medical science and academic scholarship.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Anuradha Kunthur, Author ID 12805295200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=12805295200
  2. Scientific World Research Awards. (n.d.). Innovative Research Award evaluation and recognition framework.
    https://scientificworld.net/
  3. Marisa Navoa ∙ Anuradha Kunthurb ∙ Martina L. Badell. (2006). Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients.
    https://doi.org/10.1016/j.ygyno.2006.04.002
  4. Anuradha Kunthur. (2019). A castrate-resistant metastatic prostate cancer patient with severe pancytopenia, successfully treated with docetaxel chemotherapy.
    https://doi.org/10.1177/1078155219890653

Sihe Zhang | Medicine | Distinguished Scientist Award

Published on by Scientific World Research Awards

Distinguished Scientist Award

Sihe Zhang
Nankai University, China

Sihe Zhang
Affiliation Nankai University
Country China
Scopus ID 7409373738
Documents 55
Citations 1,269
h-index 16
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-8923-1993

The Distinguished Scientist Award recognizes the scholarly achievements of Sihe Zhang, Professor and Director at Nankai University School of Medicine. His research focuses on cancer biology, drug delivery systems, endocytosis, extracellular vesicles, antibody therapeutics, and translational medicine. Through sustained contributions to hepatocellular carcinoma and ovarian cancer research, he has developed innovative approaches that connect molecular mechanisms with therapeutic applications.[1]

Abstract

Sihe Zhang is a biomedical researcher whose work spans cancer biology, antibody engineering, cellular uptake mechanisms, extracellular vesicle biology, and targeted therapeutic delivery. His investigations have contributed to understanding macropinocytosis, endocytic recycling, tumor progression, and resistance mechanisms in hepatocellular and ovarian cancers. He has also participated in the development of innovative antibody-based therapies and nanomedicine strategies aimed at improving treatment specificity and efficacy. His publication portfolio demonstrates a sustained commitment to translational medical research and interdisciplinary collaboration, supporting advancements in cancer diagnosis, drug delivery, and precision medicine.[1][2]

Keywords

Cancer Biology; Drug Delivery; Endocytosis; Extracellular Vesicles; Antibody Therapeutics; Hepatocellular Carcinoma; Ovarian Cancer; Nanomedicine.

Introduction

Professor Zhang has held academic positions at Nankai University and previously at the Fourth Military Medical University. His career reflects long-term engagement with molecular medicine and cell biology, emphasizing mechanisms that influence cancer progression and treatment response.[1]

Research Profile

His research profile combines laboratory discovery with translational applications. Major themes include cellular trafficking, therapeutic antibodies, tumor microenvironment studies, and targeted delivery platforms designed to improve treatment outcomes in oncology.[1]

Research Contributions

Notable contributions include investigations into CD147-mediated signaling, extracellular vesicle uptake, macropinocytosis-driven drug resistance, and antibody-based cancer therapies. These studies have expanded understanding of tumor biology and therapeutic targeting strategies.[2][3]

Publications

His scholarly record includes 55 indexed publications. Representative works address hepatocellular carcinoma resistance mechanisms, extracellular vesicle biology, peptide delivery systems, anti-CD147 therapeutics, and nanobiotechnology-based treatment approaches.[2][4]

Research Impact

With 1,269 citations and an h-index of 16, his research has influenced studies in cancer therapeutics, molecular oncology, and biomedical engineering. The impact of his work is reflected through citations, collaborations, and peer-review activities across leading journals.[1]

Award Suitability

The breadth of Professor Zhang’s contributions, combined with sustained publication output and translational relevance, aligns with the objectives of the Scientific World Research Awards. His work demonstrates scientific rigor and practical relevance in medicine.[1]

Conclusion

Sihe Zhang has established a recognized research portfolio in cancer biology and therapeutic innovation. His scholarly achievements and ongoing contributions support recognition through the Distinguished Scientist Award.[1]

References

  1. ORCID. (2026). Sihe Zhang (0000-0002-8923-1993) Research Profile.https://orcid.org/0000-0002-8923-1993
  2. Qian, L., et al. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates.https://doi.org/10.1016/j.drup.2025.101209
  3. Qi, F.Z., et al. (2024). Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody. MedComm.https://doi.org/10.1002/mco2.512
  4. Sun, Z., et al. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs. Biomedicines.https://doi.org/10.3390/biomedicines11071971
  5. Wang, B., et al. (2024). Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302. International Journal of Biological Sciences.https://doi.org/10.7150/ijbs.92211

Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Sedanur Güngör | Public Health | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Sedanur Güngör

Sedanur Güngör
Affiliation Gazi University
Country Turkey
Scopus ID 59374926100
Documents 4
Citations 5
h-index 1
Subject Area Public Health
Event Scientific World Research Awards
ORCID 0000-0002-3943-5365

Sedanur Güngör is a researcher affiliated with Gazi University whose academic work contributes to the fields of physiotherapy, rehabilitation sciences, and public health. Her scholarly profile includes studies related to hand rehabilitation, telerehabilitation methods, musculoskeletal disorders, and clinical assessment tools.[1] Through collaborative clinical investigations, her research reflects contemporary approaches in rehabilitation practice and patient-centered physiotherapy applications.[2]

Abstract

Sedanur Güngör has developed an emerging academic profile in public health and physiotherapy research through collaborative investigations focusing on rehabilitation sciences and clinical patient outcomes. Her published studies address telerehabilitation, grip strength evaluation, osteoarthritis, tendon repair, and virtual assessment methods in physiotherapy practice.[2] These contributions demonstrate engagement with evidence-based rehabilitation techniques and modern therapeutic technologies. Her scholarly activities also include psychometric and clinical investigations intended to improve patient care and rehabilitation efficiency.[3] The interdisciplinary nature of her work reflects the evolving integration of digital healthcare systems into rehabilitation sciences.

Keywords

Public Health, Physiotherapy, Rehabilitation Sciences, Telerehabilitation, Hand Therapy, Clinical Research

Introduction

Current rehabilitation sciences increasingly incorporate digital assessment methods and patient-centered therapy models. Sedanur Güngör’s research activity aligns with these developments through investigations involving hand rehabilitation and therapeutic evaluation systems.[2]

Research Profile

Her Scopus-indexed publications and ORCID profile document collaborative studies in physiotherapy and rehabilitation medicine. Research topics include tendon repair rehabilitation, osteoarthritis interventions, and psychometric clinical measurements.[1]

Research Contributions

Her published investigations evaluate rehabilitation effectiveness, virtual goniometric measurements, and radial nerve mobilization outcomes in clinical populations.[3] These studies contribute to evidence-based physiotherapy literature.

Publications

Research Impact

The researcher’s contributions support ongoing advancements in rehabilitation assessment and therapeutic monitoring. Her work demonstrates practical relevance for physiotherapy professionals and clinical rehabilitation researchers.[4]

Award Suitability

Sedanur Güngör’s emerging publication profile, interdisciplinary rehabilitation studies, and contributions to clinical physiotherapy research support her recognition for the Best Researcher Award under the Scientific World Research Awards program.[5]

Conclusion

The academic activities of Sedanur Güngör reflect a developing contribution to rehabilitation sciences and public health research through clinically focused physiotherapy investigations and collaborative scholarly work.

References

  1. ORCID. (2026). Sedanur Güngör researcher profile and scholarly works.
    https://orcid.org/0000-0002-3943-5365?lang=en
  2. Elsevier. (n.d.). Scopus author details: Sedanur Güngör, Author ID 59374926100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59374926100
  3. Güngör, S., et al. (2026). Virtual goniometric measurement in patients with hand and forearm injuries.
    DOI: https://doi.org/10.1080/09638288.2026.2663904
  4. Güngör, S., et al. (2026). Investigation of the effect of radial nerve mobilization on pain, function, and grip strength.
    DOI: https://doi.org/10.1016/j.physio.2026.102328
  5. Scientific World. (2026). Scientific World Research Awards official website.
    https://scientificworld.net/

Charles Dariane | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Charles Dariane | Medicine | Research Excellence Award

MD PhD | European Hospital Georges Pompidou | France

Assist. Prof. Dr. Charles Dariane is a leading researcher in urologic oncology, focusing on prostate and renal cancer, advanced imaging, and robotic-assisted surgery. His research skills include clinical trials, surgical innovation, and multidisciplinary collaboration. He has contributed to international cancer guidelines and impactful publications. His Scopus metrics include 1,429 citations, 155 documents, and an h-index of 19. His work enhances precision medicine and improves outcomes in modern urological cancer care.

 

Citation Metrics (Scopus)

1429
1000
700
300
0

Citations

1429

Documents

155

h-index

19

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Lina Posada Calderon | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Dr. Lina Posada Calderon | Medicine | Research Excellence Award

Resident | New York Presbyterian | United States

Dr. Lina Posada Calderon is an accomplished biomedical researcher at Weill Cornell Medicine, New York, specializing in translational and molecular cancer research. Her work focuses on the clinical and molecular characterization of cancers, precision oncology, biomarker discovery, and genetic drivers of tumor progression, with particular emphasis on KRAS-mutated malignancies. She has strong expertise in molecular biology, cancer genomics, clinical data analysis, interdisciplinary research, and high-impact scientific publishing. Her research bridges laboratory discoveries with patient-centered clinical outcomes. Dr. Posada Calderon has published 12 Scopus-indexed documents, receiving 61 citations, and holds an h-index of 5, reflecting her growing scholarly impact and emerging leadership in precision cancer research.

 

Citation Metrics (Scopus)

61
45
30
15
0

Citations

61

Documents

12

h-index

5

Citations

Documents

h-index

View Scopus Profile
 View Google Scholar

Featured Publications